4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001354488-16-008627
10% owner sold 2,500,000 shares at $0.32 ($792,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Camber Capital Management LLC 10% owner | 2016-12-02 | Sale | −2,500,000 | $0.32 | $792,000 | 10,775,000 | I |
| Open-market sales · 2,500,000 sh · avg $0.32 · $792,000 | |||||||
Loading xslF345X03/issuerdirect_section16.xml…